Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene Citrate + Low Dose Gonadotropins vs High Dose Gonadotropins in Poor Responders
NCT06778733Phase 1Completed
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Jan 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of clomiphene in female infertility (2 arms), sponsored by National and Kapodistrian University of Athens. Primary endpoint: Ongoing pregnancy rates at 28 months. Started Jan 2022; status: completed.
02
Drugs
clomiphene
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT06778733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06778733.